1.
Ghalavand M, Dorostkar R, Borna H, Mohammadi-Yeganeh S, Hashemi SM. MicroRNA-122 Is More Effective than Rapamycin in Inhibition of Epithelial-mesenchymal Transition and mTOR Signaling Pathway in Triple Negative Breast Cancer. Iran J Allergy Asthma Immunol. 2023;22(1):46-61.